Latigo Biotherapeutics, Inc. insider trading

LTGONASDAQ

$15.90-0.79 (-4.73%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Aug 7, 2026 to Oct 2, 2026. Price (-12.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

JBJames B. TananbaumDirector5.1502%of company
BCBeth C. SeidenbergDirector3.1596%of company
SSanofi-Aventis10% Owner1.0148%of company
NFNima FarzanPresident and CEO0.1726%of company
5V5AM Ventures VI, L.P.10% OwnerNot reportedof company
WBWestlake BioPartners Fund I, L.P.10% OwnerNot reportedof company
FCForesite Capital Management V, LLC10% OwnerNot reportedof company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
LTGO	James B. TananbaumDirector	Open market purchase$2.52M	+7.5%	$18.00	$2.52M	Aug 10, 2026	Aug 10, 2026
LTGO	Foresite Capital Management V, LLC10% Owner	Open market purchase$2.52M	+7.5%	$18.00	$2.52M	Aug 10, 2026	Aug 10, 2026

End of history · 2 transactions